Atrás
18
73
Rango del Día
$86.84
$88.36
Rango de 52 Semanas
$51.79
$101.40
Volumen
551,679
Promedio 50D / 200D
$90.26
/
$72.41
Cierre Anterior
$86.26
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 21.9 | 0.4 |
| P/B | 2.6 | 2.9 |
| ROE % | 12.3 | 3.7 |
| Net Margin % | 18.3 | 3.8 |
| Rev Growth 5Y % | 32.3 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue grew 32.34% annually over 5 years — strong growth
Earnings grew 422.31% over the past year
ROE of 12.29% — decent returns on equity
Net margin of 18.30% shows strong profitability
Debt/Equity of 0.03 — conservative balance sheet
Generating 588.77M in free cash flow
Crecimiento
Revenue Growth (5Y)
32.34%
Revenue (1Y)16.65%
Earnings (1Y)422.31%
FCF Growth (3Y)88.77%
Calidad
Return on Equity
12.29%
ROIC7.67%
Net Margin18.30%
Op. Margin16.33%
Seguridad
Debt / Equity
0.03
Current Ratio4.26
Interest Coverage0.00
Valoración
P/E Ratio
21.93
P/B Ratio2.58
EV/EBITDA23.73
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.65% | Revenue Growth (3Y) | 36.88% |
| Earnings Growth (1Y) | 422.31% | Earnings Growth (3Y) | 109.23% |
| Revenue Growth (5Y) | 32.34% | Earnings Growth (5Y) | 37.80% |
| Profitability | |||
| Revenue (TTM) | 2.94B | Net Income (TTM) | 537.90M |
| ROE | 12.29% | ROA | 10.14% |
| Gross Margin | 67.41% | Operating Margin | 16.33% |
| Net Margin | 18.30% | Free Cash Flow (TTM) | 588.77M |
| ROIC | 7.67% | FCF Growth (3Y) | 88.77% |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 4.26 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 21.93 | P/B Ratio | 2.58 |
| P/S Ratio | 4.01 | PEG Ratio | 0.05 |
| EV/EBITDA | 23.73 | Dividend Yield | 0.00% |
| Market Cap | 11.80B | Enterprise Value | 11.39B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.94B | 2.52B | 1.57B | 1.02B | 958.10M |
| Net Income | 537.90M | 102.98M | 122.87M | 190.17M | 149.19M |
| EPS (Diluted) | 3.92 | 0.75 | 1.07 | 1.85 | 1.44 |
| Gross Profit | 1.98B | 1.48B | 1.02B | 759.12M | 718.88M |
| Operating Income | 479.80M | 165.99M | 133.14M | 227.95M | 171.95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.30B | 5.25B | 5.09B | 2.08B | 1.96B |
| Total Liabilities | 729.51M | 1.07B | 1.09B | 229.75M | 215.88M |
| Shareholders' Equity | 4.57B | 4.18B | 4.00B | 1.85B | 1.74B |
| Total Debt | 118.66M | 537.19M | 520.40M | 6.01M | 0.0 |
| Cash & Equivalents | 526.16M | 784.44M | 467.29M | 150.47M | 193.07M |
| Current Assets | 2.13B | 2.18B | 1.92B | 983.34M | 864.52M |
| Current Liabilities | 498.50M | 855.91M | 392.35M | 159.20M | 140.16M |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#981 of 1024
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#33 of 326
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026